United Kingdom
Search    
Include All CSL Behring Country Sites

News

01.11.2011
CSL Behring seeks proposals for Interlaken Leadership Awards, supporting innovative research into neuroimmunology
CSL Behring has announced it is seeking proposals for the next round of Interlaken Leadership Awards as part of its continued commitment to innovative immunoglobulin (Ig) research. Established in 2010, this annual global awards programme provides monetary grants and/or product supply to advance medical research and knowledge about the potential role of immunoglobulin therapy in the treatment of neurological disorders. More.

01.04.2011
CSL Behring UK Ltd launches Riastap®, the first and only licensed fibrinogen concentrate in the UK
CSL Behring, one of the world’s leading biopharmaceutical companies specialising in the manufacture of plasma products, today announced the launch of Riastap®, the first and only licensed fibrinogen concentrate in the UK. More.

31.03.2010
CSL Behring UK Ltd supports Rare Disease UK
CSL Behring UK Ltd announced today that it had joined the patient group Rare Disease UK as an industry member. The patient group campaigns for strategic planning for rare diseases in the UK in response to unmet health care needs of hundreds of thousands of families who currently struggle to get access to integrated care and support from the NHS. More.